MDT DEF 14A DEF-14A Report Dec. 9, 2021 | Alphaminr
Medtronic plc

MDT DEF 14A Report ended Dec. 9, 2021

MEDTRONIC PLC
10-Ks and 10-Qs
10-Q
Quarter ended July 26, 2024
10-K
Fiscal year ended April 26, 2024
10-Q
Quarter ended Jan. 26, 2024
10-Q
Quarter ended Oct. 27, 2023
10-Q
Quarter ended July 28, 2023
10-K
Fiscal year ended April 28, 2023
10-Q
Quarter ended Jan. 27, 2023
10-Q
Quarter ended Oct. 28, 2022
10-Q
Quarter ended July 29, 2022
10-K
Fiscal year ended April 29, 2022
10-Q
Quarter ended Jan. 28, 2022
10-Q
Quarter ended Oct. 29, 2021
10-Q
Quarter ended July 30, 2021
10-K
Fiscal year ended April 30, 2021
10-Q
Quarter ended Jan. 29, 2021
10-Q
Quarter ended Oct. 30, 2020
10-Q
Quarter ended July 31, 2020
10-K
Fiscal year ended April 24, 2020
10-Q
Quarter ended Jan. 24, 2020
10-Q
Quarter ended Oct. 25, 2019
10-Q
Quarter ended July 26, 2019
10-K
Fiscal year ended April 26, 2019
10-Q
Quarter ended Jan. 25, 2019
10-Q
Quarter ended Oct. 26, 2018
10-Q
Quarter ended July 27, 2018
10-K
Fiscal year ended April 27, 2018
10-Q
Quarter ended Jan. 26, 2018
10-Q
Quarter ended Oct. 27, 2017
10-Q
Quarter ended July 28, 2017
10-K
Fiscal year ended April 28, 2017
10-Q
Quarter ended Jan. 27, 2017
10-Q
Quarter ended Oct. 28, 2016
10-Q
Quarter ended July 29, 2016
10-K
Fiscal year ended April 29, 2016
10-Q
Quarter ended Jan. 29, 2016
10-Q
Quarter ended Oct. 30, 2015
10-Q
Quarter ended July 31, 2015
10-K
Fiscal year ended April 24, 2015
10-Q
Quarter ended Jan. 23, 2015
PROXIES
DEF 14A
Filed on Aug. 9, 2024
DEF 14A
Filed on Aug. 11, 2023
DEF 14A
Filed on Aug. 19, 2022
DEF 14A
Filed on Aug. 27, 2021
DEF 14A
Filed on Aug. 14, 2020
DEF 14A
Filed on Aug. 16, 2019
DEF 14A
Filed on Aug. 24, 2018
DEF 14A
Filed on Aug. 28, 2017
DEF 14A
Filed on Aug. 10, 2016
DEF 14A
Filed on July 24, 2015
TABLE OF CONTENTS
PROXY SUMMARYCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSPROPOSAL 1 ELECTION OF DIRECTORSDirectors and NomineesCORPORATE GOVERNANCECorporate Governance PrinciplesBoard Performance EvaluationsLead Independent Director and Chairman; Executive SessionsBoard Role in Risk OversightCompensation Risk AssessmentCommittees of the Board and MeetingsDirector IndependenceRelated Party Transactions and Other MattersComplaint Procedure; Communications with DirectorsCodes of ConductDirector CompensationSHARE OWNERSHIP INFORMATIONSignificant ShareholdersBeneficial Ownership of ManagementDelinquent Section 16(a) ReportsCOMPENSATION DISCUSSION AND ANALYSISExecutive SummaryParticipants in Executive Compensation Design and Decision-Making ProcessExecutive Compensation Program DesignHow We Establish Executive Compensation LevelsFiscal Year 2021 Compensation DecisionsFiscal Year 2021 Annual Medtronic Incentive Plan (MIP) DesignFiscal Year 2022 Annual Medtronic Incentive Plan (MIP) Design ChangeFiscal Year 2021 Long-Term Incentive Plan (LTIP) DesignFiscal Year 2021 Annual and Long-Term Incentive Plan PayoutsExecutive Compensation Governance Practices and PoliciesOther Benefits and PerquisitesCOMPENSATION COMMITTEE REPORTEXECUTIVE COMPENSATION2021 Summary Compensation Table2021 Grants of Plan-Based Awards2021 Outstanding Equity Awards at Fiscal Year End2021 Option Exercises and Stock Vested2021 Pension Benefits2021 Nonqualified Deferred CompensationPotential Payments Upon Termination or Change of ControlEquity Compensation Plan Information